Name: HMP Global - test dupe
Start: 12/06/2024 12:00 PM +00:00
End: 06/09/2024 08:25 PM +00:00

Teva Medical Affairs Teva Pharmaceuticals has been developing and producing medicines to help improve people&rsquo;s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,600 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products.

Teva Medical Affairs

We are the force behind Healthcare Made Practical. We are an omnichannel leader in healthcare events and education, with a mission to improve patient care. We produce accredited medical education events &ndash; in person and online via our VRTX virtual platform &ndash; and clinically relevant, evidence-based content for the global healthcare community across a range of therapeutic areas.

Psych Congress NP Institute

Welcome to Sana Symposium. We are your premier resource for staying up to date on the latest clinical advances in research breakthroughs and expert-guided strategies in the field of psychedelic therapies.

Sana Symposium

WoundCon

Urgo Medical

Otsuka Pharmaceuticals, Inc

Convatec

Kick off an exceptional day of learning by joining Psych Congress Regionals expert faculty for a brief roundtable discussion about the state of mental healthcare – what’s here, what’s new, and what’s next. Gain unique perspectives on everything from disease-states to the work-life-balance of today’s clinicians and blooming opportunities in treatment.

Rakesh Jain

Saundra Jain

Andrew Penn

Vanessa Walker

Morning Roundtable

This insightful discussion will delve into the latest findings on ADHD's etiology, recent genetic insights, and neurobiological foundations, shedding light on their potential implications for clinical practice. Participants will gain a comprehensive understanding of the relationship between neurotransmission changes in ADHD and their impact on treatment options. Moreover, the session will equip attendees with best practices for diagnosing and treating ADHD, emphasizing the importance of considering relevant gender differences to achieve optimal outcomes in clinical settings.

Vladimir Maletic

ADHD is Not What We Thought It is: Clinical Translation of New Perspectives on ADHD

Innovation Theaters (Non-Accredited)

Master Class - To be Announced

Master Class - To Be Announced

Join expert panelists from sessions throughout this section of the day as they answer your most pressing and popular questions from sessions so far.

Craig Chepke

Jonathan Meyer

Desiree Matthews

LIVE Q&A Session

Greg Mattingly

This session will explore the intricate landscape of benzodiazepine treatment for anxiety disorders, providing clinicians with essential insights to optimize patient care. Participants will evaluate the nuanced risk-benefit profile of benzodiazepines as a first-line therapy, considering effectiveness, side effects, and long-term outcomes. Additionally, attendees will explore the diverse spectrum of treatment options for anxiety, including cognitive-behavioral therapy, motivational interviewing, shared decision-making, and psychoeducation, comparing their roles to benzodiazepine use. By the end of the session, clinicians will be equipped to develop comprehensive deprescribing strategies, identifying appropriate discontinuation scenarios, engaging in shared decision-making processes with patients, and seamlessly integrating alternative therapeutic modalities like CBT and MI into their treatment plans.

Manish Jha

Navigating Complexity: Striking the Right Balance with Benzodiazepine Use for Anxiety Disorders

Join Dr. Saundra Jain as she consults our experts on varying mental health care challenges. We will engage with Dr. Charles Raison, who will answer some of the most challenging questions asked among patients and clinicians. Then we will hear from Dr. Marc Agronin, who will be addressing the challenges associated with geriatric patient care. To end the session, the interviewer becomes the interviewee as Dr. Saundra Jain talks about the WILD 5 path to wellness program.

Charles Raison

Marc Agronin

Ask the Experts

Close out an exceptional day of learning by joining Psych Congress Regionals expert faculty for a brief roundtable discussion about the state of mental healthcare – what’s here, what’s new, and what’s next. Gain unique perspectives on everything from disease-states to the work-life-balance of today’s clinicians and blooming opportunities in treatment.

Agenda

Speakers.css-2zwi6c{margin:0;font-size:1.4rem;font-weight:500;line-height:1.5;color:#494949;font-family:'Poppins',sans-serif;margin-left:0.8rem;}32 Speakers

Charles Raison

Steven Chan

Marc Agronin

Manish Jha

Craig Chepke

Greg Mattingly

Jonathan Meyer

Amber Hoberg

Nicole Cirino

Rakesh Jain

Saundra Jain

Vladimir Maletic

Andrew Penn

Julie Carbray

Ilan Melnick

Arwen Podesta

Edward Kaftarian

Jill Harkavy-Friedman

Leslie Citrome

Samantha Lau

Kali Cyrus

Vanessa Walker

Andrew Smith

Desiree Matthews

Kevin Williams

Brooke Kempf

Chelsie Monroe

Peter Weiden

Michael Pollock

Jo Hughes

Chrissy Brunick

Karen Quinlisk

Booth.css-14sv5ey{margin:0;font-size:1.4rem;font-weight:500;line-height:1.5;color:#494949;font-family:'Poppins',sans-serif;color:#FFFFFF;margin-left:0.8rem;font-weight:400;}7 Booth